Hem › Ewing-sarkom › Ohio
Kliniska studier för Ewing-sarkom i Ohio
8 studier för Ewing-sarkom söker deltagare vid platser i Ohio.
Städer i Ohio
Officiell studietext (engelska)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Cleveland Clinic Children's, Cleveland
- Nationwide Children's Hospital, Columbus
RekryterarFas 1
Ålder 1 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07194044Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekryterarFas 1
Ålder 12 till 85 · Alla kön · Uppdaterad 8 sep. 2026 · NCT03715933Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 6 aug. 2026 · NCT05210374Single Arm Romiplostim to Prevent CIT
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekryterarTidig fas 1
Ålder 1 och äldre · Alla kön · Uppdaterad 18 mars 2026 · NCT07048249A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- The Ohio State University Wexner Medical Center, Columbus
Rekryterar
Ålder 13 och äldre · Alla kön · Uppdaterad 6 feb. 2026 · NCT06387485Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekryterarFas 1/2
Ålder 2 till 30 · Alla kön · Uppdaterad 3 feb. 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
RekryterarFas 2
18 Months – 40 Years · Alla kön · Uppdaterad 12 aug. 2025 · NCT05135975Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.